Why Don't We Have a Vaccine Against Autoimmune Diseases? - A Review


Why Don't We Have a Vaccine Against Autoimmune Diseases? - A Review


Rosenthal Ken S; Carambula Roy; Zimmerman Daniel H


Journal of Clinical & Cellular Immunology




This review examines some of the reasons why we don't have a vaccine against autoimmune diseases and highlights the progress that has been made. Many autoimmune diseases, such as rheumatoid arthritis (RA), multiple sclerosis (MS) and type 1 diabetes (T1D), are driven by autoimmune T cell responses. Unlike vaccines for most infectious diseases, which elicit antibody responses, are intended for immuno-naive individuals and considered preventative, a vaccine for an autoimmune disease must be therapeutic and resolve or control the on-going autoimmune response and condition in the diseased host. Despite these differences, many of the same considerations for infectious disease vaccines must also be addressed to develop a therapeutic vaccine for autoimmune diseases. The disease initiator/triggers, antigens and autoantigens, nature of the immunopathogenic and protective/therapeutic immune response will be compared for infectious and autoimmune diseases as will approaches for developing vaccines including formulations, animal models and indicators of success. The rationale for a therapeutic vaccine for RA will be discussed in greater detail with a relatively limited discussion of T1D, MS and other autoimmune diseases.


Autoimmune; Immunotherapy; Multiple sclerosis; Rheumatoid arthritis; Type 1 diabetes; Vaccine

Search for Full-text

Users with a NEOMED Library login can search for full-text journal articles at the following url: https://libraryguides.neomed.edu/home


Article information provided for research and reference use only. All rights are retained by the journal listed under publisher and/or the creator(s).






Rosenthal Ken S; Carambula Roy; Zimmerman Daniel H, “Why Don't We Have a Vaccine Against Autoimmune Diseases? - A Review,” NEOMED Bibliography Database, accessed December 1, 2022, https://neomed.omeka.net/items/show/6525.

Social Bookmarking